Skip to main content
Richard Russell

Dr Richard Russell

Interim Head of Department, Peter Gorer Department of Immunobiology

  • Clinical Reader

Biography

Dr Richard Russell is a the Head of Department, Peter Gorer Department of Immunobiology and a Clinical Reader in the School of Immunology & Microbial Sciences at King's College London.

    Research

    Transdiagnostic biological clustering
    Clinical Diagnostics Development Unit (CDDU)

    The CDDU ethos is to harmonise all methods used within the labs for the processing of clinical samples.

    Lung thumbnail
    King's Centre for Lung Health

    Promoting lung health throughout the lifetime, by preventing, diagnosing and treating lung disease.

    News

    First new treatment for asthma attacks in 50 years

    An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further...

    asthma-lab

    New heart disease calculator could save lives by identifying high-risk patients missed by current tools

    The collaborative research, led from the University of Oxford, has developed a new tool that more accurately predicts risk of cardiovascular diseases

    congenital heart disease

      Research

      Transdiagnostic biological clustering
      Clinical Diagnostics Development Unit (CDDU)

      The CDDU ethos is to harmonise all methods used within the labs for the processing of clinical samples.

      Lung thumbnail
      King's Centre for Lung Health

      Promoting lung health throughout the lifetime, by preventing, diagnosing and treating lung disease.

      News

      First new treatment for asthma attacks in 50 years

      An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further...

      asthma-lab

      New heart disease calculator could save lives by identifying high-risk patients missed by current tools

      The collaborative research, led from the University of Oxford, has developed a new tool that more accurately predicts risk of cardiovascular diseases

      congenital heart disease